Innovus Pharma (INNV) Reports Q1 Loss of $0.01

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. COF
6. SMCI
7. RTX
8. TSLA
9. GOOGL
10. S

Go back to Innovus Pharma (INNV) Reports Q1 Loss of $0.01

Innovus Pharmaceuticals Reports Record Quarterly Revenue for the First Quarter 2018 of $4.5 million, Beating Previous Estimate and Net Loss Decrease of 28% Compared to the Same Quarterly Period in 201

May 14, 2018 4:05 PM EDT

Quarterly Net Revenue Increase of 109% When Compared to the First Quarter of 2017

SAN DIEGO--(BUSINESS WIRE)-- Innovus Pharmaceuticals, Inc., (Innovus Pharma or the Company) (OTCQB: INNV), today announced first quarter 2018 net revenue of $4.5 million compared to $2.2 million in net revenue for the same period in 2017.

We are delighted with our first quarter net revenues of $4.5 million, which beat our previously announced first quarter expectations, stated Bassam Damaj, President and Chief Executive Officer of Innovus Pharma. We are very confident in our business strategy and in our ability to grow our sales revenue... More